ACE2016 Is an Allogeneic Gamma Delta 2 (?d2) T Cell Therapy Targeting the Epidermal Growth Factor Receptor (EGFR) in Patients With Solid Tumors. Phase 1 Clinical Study Expected to Begin in H2 2024. ALAMEDA, Calif. and TAIPEI , Feb. 4, ...
KRAKOW , Poland , Jan. 31, 2024 /PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, announced today ...
Pancreatic cancer has the highest mortality rate of all major cancers with only a 3% relative-survival-rate at 5-years for the advanced form. [1], [2] Pancreatic tumors are highly resistant to chemotherapy and radiation and there are ...
ARCADIA, Calif. , Jan. 29, 2024 /PRNewswire/ -- Theragent Inc., a comprehensive CDMO focused on advancing next-generation cell-based therapies, has announced that its sponsor client, CellVax Therapeutics Inc., received clearance of its ...
NEW YORK , Jan. 29, 2024 /PRNewswire/ -- Leal Health ("Leal" or "the Company"), formerly known as Trialjectory, a patient-first, AI-powered treatment platform revolutionizing patient access to cancer care, announced today that the ...
SHANGHAI , Jan. 29, 2024 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary ...
SHANGHAI , Jan. 29, 2024 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary ...
SHANGHAI , Jan. 25, 2024 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary ...
- BSI-082 is a fully human anti-SIRPa antagonistic monoclonal antibody with potential broad combo therapies for the treatment of hematologic and solid tumors NEWARK, Del. and NANJING , China , Jan. 24, 2024 /PRNewswire/ -- Biosion ...
Study published in NAR Cancer, a leading peer-reviewed journal in the field of nucleic acid therapeutics HONG KONG , Germantown, Md. and SUZHOU, China , Jan. 24, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: ...
Groundbreaking research introduces drug-loaded 3D printed films that could revolutionize cancer treatments. These innovative films, containing tailored doses of anti-cancer drugs 5-fluorouracil (5FU) and cisplatin (Cis), not only eliminate over 80% ...
Patients with locally advanced prostate cancer experience prolonged control of prostate-specific antigen (PSA) levels when treated with a combination of chemotherapy and hormonal therapy, as opposed to hormonal therapy alone ( ). " Our ...
A recent study published in JNCI Cancer Spectrum by Oxford University Press indicates that adopting a healthy diet can reduce the risk of cardiovascular disease among breast cancer survivors ( ). Cardiovascular ...
Scientists have developed a urine test capable of detecting DNA fragments shed by head and neck tumors. This innovative test has the potential to enable early detection of this cancer type, for which there is currently no dependable screening method ...
In breast cancer ( ) patients, depression significantly heightens mortality risk. Breast cancer is the most prevalent cancer among females and a leading global cause of death. ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers